Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.

• Source: Shutterstock

Bausch + Lomb, Corporation’s sales are growing across its three segments not only on the products in the portfolio of each one but also on cross-segment exposure from some of the Canadian firm’s pharma, surgical and consumer health vision health and eye care products.

The Blink NutriTears dietary supplement containing lutein/zeaxanthin, curcumin and vitamin D3 the firm announced on 25 April and plans to...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Earnings

More from Business